LFWD — Lifeward Ltd.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1607962 ·
Last close
$6.98
Market Cap
$19.39M
52W High
$7.69
52W Low
$5.08
ADV30
9,290
Next earnings
2026-08-13
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026
Dec 2025 5,081,000 1,088,000 -5,118,000 -5,348,000 22,900,000 2,169,000 14,492,000
Sep 2025 6,195,000 2,707,000 -3,140,000 -3,170,000 23,168,000 1,956,000 10,413,000
Jun 2025 5,724,000 2,511,000 -3,780,000 -6,562,000 26,777,000 5,139,000 11,667,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-16,826,000
Investing CF
$-16,000
Financing CF
$12,203,000
CapEx
$-16,000
Dividends Paid
Buybacks
$0
EPS Diluted TTM
$-18.49
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-284,739,000
Inventory
$5,732,000
Receivables
$6,138,000
ST Investments
EBIT TTM
$-16,891,000
Pretax Income TTM
$-19,969,000
Interest Exp TTM
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$20,923,000
EBITDA
$-17,092,750
Free Cash Flow
$-8,679,875
Enterprise Value
$8,749,331
Total Cash
$11,422,000
Total Debt
$8,814,000
Shares Out
2,778,585
Trailing EPS
$-18.55
Book Value
$5.52
ROE
-209.1%
ROA
-35.0%
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 22,034,000 -16,891,000 -19,914,000 22,900,000 14,492,000 -16,826,000
Dec 2024 25,663,000 -19,553,000 -28,942,000 30,487,000 11,638,000 -21,718,000
Dec 2023 13,854,000 -23,612,000 -22,133,000 63,192,000 16,682,000 -20,667,000
Dec 2022 5,511,000 -19,102,000 -19,569,000 74,236,000 6,071,000 -17,891,000
Dec 2021

TTM Snapshot

Revenues TTM
$2,897,000
NetIncome TTM
$-12,240,000
OpCashFlow TTM
$0
Assets (Latest)
$22,863,000
Forward EPS
$-1.78

Peers — same industry

TickerNameMarket CapLastDaily %
ICCM IceCure Medical Ltd. $18.40M $0.23
GTHP GUIDED THERAPEUTICS INC $18.34M $0.19
RVP RETRACTABLE TECHNOLOGIES INC $20.66M $0.69
IRIX IRIDEX CORP $18.10M $1.04
OSRH OSR Holdings, Inc. $17.38M $0.50

News headlines (Yahoo Finance, 1h cache)

Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform
2026-05-19 12:00 · Yahoo
How The Lifeward (LFWD) Story Is Shifting With New Price Targets And Valuation Assumptions
2026-05-17 13:13 · Yahoo
Lifeward Ltd (LFWD) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing Growth ...
2026-05-15 23:01 · Yahoo
Lifeward (LFWD) Q1 2026 Earnings Transcript
2026-05-15 17:00 · Yahoo
Lifeward Ltd. Q1 2026 Earnings Call Summary
2026-05-15 16:42 · Yahoo
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates
2026-05-15 14:05 · Yahoo
Lifeward Reports First Quarter 2026 Financial Results
2026-05-15 12:00 · Yahoo
Keros Therapeutics, Inc. (KROS) Reports Q1 Loss, Misses Revenue Estimates
2026-05-14 13:10 · Yahoo
Walk Assist Robot Market Research Report 2026-2031: Leading firms Such as Ekso Bionics, Lifeward, Cyberdyne, Ottobock, and DIH Medical Lead the $568.81 Million Market
2026-05-14 09:11 · Yahoo
Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026
2026-05-11 13:25 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.